Latest Rhinitis Stories

Neti Pots Show Increase In Searches, Social Media "Chatter," As Consumers Seek Protection Ideas Above and Beyond CDC Recommendations MADISON, Wis., May 4 /PRNewswire/ -- Add nose washing to the steps that consumers are looking to take -- in addition to frequent hand washing and coughing in a tissue -- in an effort to avoid infection with the flu. According to data from Google Insights For Search, "neti pot" increased as a search term some 15-20% last week, with New York and California in...

ANTONY, France, April 29 /PRNewswire-FirstCall/ -- Stallergenes S.A. announces the release of the first year outcome of its phase IIb/III clinical trial (VO 57.07) on a sublingual house dust mite desensitization tablet. "We are very pleased with the outcome of this study, which is the first large study to ever demonstrate the efficacy of house dust mites allergen in treating perennial allergic rhinitis. Furthermore, the unexpected quick onset of action and the good safety profile...

Children with allergies and asthma may benefit from an allergy evaluation, a U.S. allergist advises. Dr. Maya Jerath of the University of North Carolina at Chapel Hill School of Medicine says controlling allergy symptoms can prevent some of the common complications of untreated allergies like sinusitis and ear infections. Some sufferers seek relief with supplements like vitamin C or zinc, Jerath said. These supplements may help with colds, but there are no studies showing they work for...

OXFORD, England, April 21 /PRNewswire/ -- Circassia Ltd, a specialty biopharmaceutical company focused on allergy, announced today that it has initiated a phase II clinical study of its ToleroMune(R) technology in allergy patients with asthma. The trial builds on positive phase II results that demonstrated the potential clinical benefits of ToleroMune allergy therapy, and extends clinical investigations to those with allergy-associated asthma. The lastest study, which is underway...

First Selective TLR8 Agonist to Advance for Treatment of Allergy SAN DIEGO, April 16 /PRNewswire/ -- VentiRx Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of novel Toll-Like Receptor 8 (TLR8) agonists for the treatment of cancer, respiratory and inflammatory diseases, announced today that it has initiated a Phase I clinical trial of VTX-1463, a selective intranasal TLR8 agonist for the treatment of allergic rhinitis. The objectives of this trial will be to...

- TV Host Explains How Talking to a Pharmacist Helped Her Manage Her Congestion so She Can Get Back to Her Busy Schedule - WASHINGTON, D.C., April 2 /PRNewswire/ -- Mom, actress and allergy sufferer Alison Sweeney knows first hand how symptoms like congestion can make juggling a busy career and family life even more challenging. That's why she's teamed up with the American Pharmacists Association (APhA) and McNeil Consumer Healthcare Division of McNEIL-PPC, Inc. to launch Behind the...

Alleviating springtime allergies begins with avoiding pollen, if possible, a U.S. doctor advises. Dr. Catherine Monteleone, a board-certified allergist at the University of Medicine and Dentistry of New Jersey, suggests keeping car and home windows closed and, if necessary, the air conditioner on. If you have to be outside, wear sunglasses to shield your eyes from pollen and do activities later in the day, because pollen is released early, Monteleone says in a statement. When you return...

IRVINGTON, N.Y., March 11 /PRNewswire/ -- Spring has sprung and with it arrives the onset of unrelenting allergy symptoms which for many, will persist throughout the season into summer. For over 40 million Americans in search of allergy relief this season, a solution can't come fast enough. This year, experts predict pollen counts will reach all-time highs due to global warming. Fortunately, there is new hope for sufferers. Chloraseptic(R) Allergen Block and Little Allergies(R) Allergen...

Fluticasone Propionate Nasal Spray (FLONASE(R)) will be the first product marketed under this arrangement MASON, Ohio, March 11 /PRNewswire/ -- Prasco Laboratories, announced today it has entered into a marketing and distribution agreement with GlaxoSmithKline (NYSE: GSK). FLONASE(R) (fluticasone propionate) Nasal Spray is the first product to be marketed under this agreement. Prasco, as GSK's agent and on GSK's behalf, will solicit orders for, and distribute Fluticasone Propionate Nasal...

Broccoli and other cruciferous vegetables may help protect against respiratory inflammation that causes conditions like asthma, U.S. researchers said. Researchers at the University of California, Los Angeles, said that the naturally occurring compound found in broccoli -- sulforaphane -- and other cruciferous vegetables may help protect against respiratory inflammation that causes conditions such as asthma, allergic rhinitis and chronic obstructive pulmonary disease. This is one of the...